SCHEMBL27793003

SCHEMBL27793003

CCOC(=O)C(C)N1CCSCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
GAA P10253 3/20 0.41
HPGD P15428 2/20 0.41
KDM4E B2RXH2 1/20 0.41
HSD17B10 Q99714 1/20 0.41
KMT2A Q03164 3/20 0.40
LMNA P02545 1/20 0.40
MAPT P10636 1/20 0.40
RAB9A P51151 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
CYP2C19 P33261 2/20 0.38
MEN1 O00255 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP3A4 P08684 1/20 0.37
FDPS P14324 1/20 0.37
TSHR P16473 2/20 0.36
DPP4 P27487 3/20 0.35
DPP8 Q6V1X1 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6129180 0.86 ALDH1A1 (0.46) ALDH1A1GAAHPGDHSD17B10KMT2A
SCHEMBL4089646 0.82 ALDH1A1 (0.43) ALDH1A1GAAHPGDKMT2ALMNA
SCHEMBL3898658 0.82 ALDH1A1 (0.43) ALDH1A1GAAHPGDHSD17B10KMT2A
SCHEMBL28201107 0.82 ALDH1A1 (0.43) ALDH1A1GAAHPGDKMT2ALMNA
SCHEMBL2961890 0.81 ALDH1A1 (0.42) ALDH1A1GAAHPGDKDM4EKMT2A
SCHEMBL2110264 0.78 SIGMAR1 (0.42) ALDH1A1GAAHPGDKMT2ALMNA
SCHEMBL3358932 0.78 ALDH1A1 (0.40) ALDH1A1GAAHPGDKDM4EHSD17B10
SCHEMBL7297454 0.78 ALDH1A1 (0.65) ALDH1A1GAAHPGDKMT2ALMNA
SCHEMBL16496970 0.78 KDM4E (0.46) ALDH1A1GAAHPGDKDM4EKMT2A
SCHEMBL3353702 0.78 ALDH1A1 (0.40) ALDH1A1GAAHPGDKDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101610813-A Quinuclidinol derivatives as muscarinic receptor antagonist ASTRAZENECA AB (SE) 2009-12-23 CN disclosed